Journal Club - Early Phase Clinical Trials

Add to:

Chair: Alun Bedding, Director, GlaxoSmithKline

Speaker: Timothy H Montague, GlaxoSmithKline
Sequential design approaches for bioequivalence studies with crossover designs
Co-authors: Diane Potvin, Charles E. DiLiberti, Walter W. Hauck, Alan F. Parr, Donald J. Schuirmann and Robert A. Smith
Pharmaceutical Statistics, Volume 7, Issue 4, October/December 2008, Pages: 245–262

Plus information from:
Additional results for ‘Sequential design approaches for bioequivalence studies with crossover designs’

(Subsequently published in: Pharmaceutical Statistics, Volume 11, Issue 1, pages 8–13, January/February 2012)
Abstract | Paper+Slides

Speaker: Ileana Baldi, Unit of Cancer Epidemiology, CeRMS and CPO Piemonte, University of Turin
Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas
Co-authors: Sarah Zohar, Guido Forni, Franco Merletti, Giuseppe Masucci and Dario Gregori
Pharmaceutical Statistics, Volume 10, Issue 3, pages 218–226, May/June 2011
Abstract | Paper+ | Slides

+ Papers available to view from 14th July 2011 to 11th August 2011.

​For a flier advertising the event, please click here.

Upcoming Events

Latest Jobs